Graham K Cooper is Director of Nuvation Bio Inc.. Currently has a direct ownership of 25,000 shares of NUVB, which is worth approximately $67,000. The most recent transaction as insider was on Feb 10, 2021, when has been sold 25,000 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K
0% 3M change
0% 12M change
Total Value Held $67,000

GRAHAM K COOPER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2021
BUY
Exercise of conversion of derivative security
-
25,000 Added 50.0%
25,000 Class A Common Stock

Also insider at

BEAM
Beam Therapeutics Inc. Healthcare
AMTI
Applied Molecular Transport Inc. Healthcare
UBX
Unity Biotechnology, Inc. Healthcare
KZR
Kezar Life Sciences, Inc. Healthcare
GKC

Graham K Cooper

Director
Cambridge, MA

Track Institutional and Insider Activities on NUVB

Follow Nuvation Bio Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVB shares.

Notify only if

Insider Trading

Get notified when an Nuvation Bio Inc. insider buys or sells NUVB shares.

Notify only if

News

Receive news related to Nuvation Bio Inc.

Track Activities on NUVB